Trademark Overview
On Friday, December 6, 2024, a trademark application was filed for CRDMO+ with the United States Patent and Trademark Office. The USPTO has given the CRDMO+ trademark a serial number of 98888717. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Friday, June 6, 2025. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The CRDMO+ trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:
custom assembling of materials for others; processing or treating of chemical reagents; processing of antibody drugs; custom manufacturing of Antibody drugs; custom production of biological preparations; processing of biomedical preparations; processing of biotechnology drug; processing of pharmaceutical preparations; custom manufacturing of pharmaceuticals; custom manufacture of biopharmaceuticals;
consulting services in the field of technology development; research and development of new products for others; research and development of new products; scientific research and development; pharmaceutical drug development services; pharmaceutical research services; biochemical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; biological research; biomedical research services; veterinary research; biotechnology research;
